Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Antibiotic Resistance Companies

Antibiotic resistance occurs when bacteria or other microorganisms develop the ability to resist the effects of antibiotics, making infections harder to treat and increasing the risk of spread to others. Several companies are actively involved in addressing antibiotic resistance through the development of new antibiotics, diagnostic tools, and strategies to combat drug-resistant infections.

Antibiotic Resistance Key CompaniesLatest Antibiotic Resistance Companies Update

November 2023: Glox pharmaceuticals, a biotechnology firm specializing in the advancement of precision antibiotic medicines, has successfully secured a seed investment round amounting to USD 4.5 million. The primary objective of this money is to facilitate the development of highly efficient targeted pharmaceuticals specifically designed to combat antibiotic-resistant bacteria. The recently established company is at the forefront of developing advanced antibiotic treatments that utilize naturally occurring bacteriocins to specifically target highly resistant and potentially more harmful 'gram-negative' bacteria. The allocated funds will be utilized to create facilities in Oxford and Glasgow, as well as to augment the existing research team. Antimicrobial resistance (AMR) is responsible for an approximate annual loss of 1.27 million lives globally, as a result of the ineffectiveness of currently available medicines in treating infections.


July 2023: EMPE Diagnostics introduced the mfloDx MDR-TB test kit, which is a unique and pioneering diagnostic tool. This test kit utilizes a combination of molecular and sensitive lateral flow biosensors to effectively detect the presence of tuberculosis (TB) bacteria and accurately identify antibiotic resistance. Notably, this test kit is the first of its kind globally. Furthermore, it is capable of delivering results within a timeframe of less than three hours, making it particularly suitable for implementation in clinics with limited resources. It is a source of great satisfaction that the development and manufacturing of the product took place within the Genome Valley, a location of significance. The mfloDx MDR-TB kit is a cost-effective and efficient diagnostic tool that offers prompt and precise results pertaining to the bacteria and its resistance characteristics.List of Antibiotic Resistance Key companies in the market

• Achaogen Inc. (US)


• Basilea Pharmaceutica Ltd. (Switzerland)


• MELINTA THERAPEUTICS INC. (US)


• PARATEK therapeutics (US)


• Seres Therapeutics (US)


• Theravance Biopharma (UK)


• Entasis Therapeutics (US)


• Tetraphase Pharmaceuticals (US)


• Nabriva Therapeutics plc (Ireland)


• NEMESIS BIOSCIENCE LTD (UK)

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.